retatrutide and heart Why some of my patients are stopping 🔬 Retatrutide — why cardiology

Semaglutide also slows gastric emptying, meaning food stays in your stomach longer

The retatrutide availability timeline depends on ongoing clinical trials and regulatory review: Current status: Multiple phase 3 trials (TRIUMPH program) ongoing Phase 3 primary completion: Expected through mid-year NDA submission: Eli Lilly expected to submit to FDA in late future FDA review period: Approximately 10 months after submission Estimated approval: Potentially late next year at earliest Commercial launch: Could follow shortly after approval It is important to note that Eli Lilly has not announced an official filing timeline

Talk to your doctor to see if this program is right for you

Lucie, Vero Beach, Micco, and Melbourne, and we also help clients in Lancaster, PA